The ADAC Reassessment of clinical competency module is designed for registered nurses required to demonstrate continuing maintenance of clinical skills. The biannual reassessment of clinical competency uses standardised reassessment of clinical competency tools for a certain skills level i.e. either 1) Administration of oral antineoplastic drugs or 2) Administration of intravenous antineoplastic drugs. This course is worth 2 hours of Professional Development time |
|
- Editing Trainer: Anne Thomas
This module is appropriate for clinical staff who need to develop competency with oral administration but will not be administering intravenous antineoplastic drugs. The Antineoplastic Drug Administration Course (ADAC) supports health professionals develop the necessary knowledge and clinical skills to administer antineoplastic drugs via different routes and handle related waste safely. ADAC uses eviQ content to develop education courses that are based upon the best and most comprehensive evidence available at the time of development. ADAC was developed by the Cancer Institute NSW and follows a strict governance process. The course includes high quality interactive scenario based eLearning guides, eQuizzes, supervised clinical practice, competency assessments and a clinical skills workshop to consolidate theory to practice. It is recommended that clinical participants meet the following prerequisites:
This course is worth 10 hours of Professional Development time |
|
- Key contact: Erin Snaith
- Editing Trainer: Anne Thomas
This course is appropriate for health professionals who are administering antineoplastic drugs in the non-cancer clinical setting to patients who do not have a cancer diagnosis This course is worth 4 hours of Professional Development time |
- Key Contact: Erin Snaith
- Editing Trainer: Anne Thomas
This course is appropriate for both clinical and non clinical staff and may be the course for participants who only need to develop an understanding of the principles of safe handling and competency with this procedure but who will not be administering antineoplastic drugs. This course is worth 2 hours of Professional Development Time |
- Key Contact: Gail Haines
- Key Contact: Melissa Higson
- Key Contact: Olivia Pearse
- Key Contact: Erin Snaith
- Key Contact: Anne Thomas